Lite Strategy (LITS) Cash & Equivalents (2010 - 2026)
Lite Strategy's Cash & Equivalents was $5.71 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 68.3% from $18.01 million a year earlier and down 24.4% from the prior quarter.
Powered by 
Analysis
Lite Strategy (LITS) Cash & Equivalents (2010 - 2026) Analysis & Trends
From fiscal Q1 2011 onward, Lite Strategy has reported Cash & Equivalents for 64 quarters.
- Cash & Equivalents shows a five-year compound annual growth rate of -7.8% (FY2021 to FY2026).
- In earlier fiscal years, Cash & Equivalents was $18.01 million in FY2025 (+386.1%), $3.71 million in FY2024 (-78.1%), $16.91 million in FY2023 (+7.4%) and $15.74 million in FY2022 (+84.2%).
- The fiscal Q4 2026 figure marks the lowest quarterly Cash & Equivalents since fiscal Q4 2024.
- Compared with a year earlier, Cash & Equivalents has declined for three straight quarters, with growth averaging 183.3% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was fiscal Q3 2025 (growth of 764.5%); the worst was fiscal Q4 2024 (a decline of 78.1%).
- Per Business Quant data, LITS's Cash & Equivalents in the three fiscal quarters before Q4 2026 was $7.54 million (Q3 2026), $8.76 million (Q2 2026) and $10.11 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Lite Strategy | 40.09 Mn | 7.97 Mn | - | 5.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.71 Mn |
| Mar 31, 2026 | 7.54 Mn |
| Dec 31, 2025 | 8.76 Mn |
| Sep 30, 2025 | 10.11 Mn |
| Jun 30, 2025 | 18.01 Mn |
| Mar 31, 2025 | 20.47 Mn |
| Dec 31, 2024 | 23.74 Mn |
| Sep 30, 2024 | 6.95 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 5.17 Mn |
| Sep 30, 2023 | 3.37 Mn |
| Jun 30, 2023 | 16.91 Mn |
| Mar 31, 2023 | 8.81 Mn |
| Dec 31, 2022 | 10.92 Mn |
| Sep 30, 2022 | 14.65 Mn |
| Jun 30, 2022 | 15.74 Mn |
| Mar 31, 2022 | 11.11 Mn |
| Dec 31, 2021 | 12.55 Mn |
| Sep 30, 2021 | 15.62 Mn |
API Access
Lite Strategy Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LITS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "LITS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LITS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();